|1.||Baird, Andrew: 2 articles (08/2009 - 07/2006)|
|2.||Logan, Ann: 2 articles (08/2009 - 07/2006)|
|3.||Gonzalez, Ana Maria: 2 articles (08/2009 - 07/2006)|
|4.||Berry, Martin: 2 articles (08/2009 - 07/2006)|
|5.||Pennartz, Sandra: 1 article (07/2015)|
|6.||Caspary, Lixi: 1 article (07/2015)|
|7.||Winkelmann, Ria: 1 article (07/2015)|
|8.||Reiß, Sandy: 1 article (07/2015)|
|9.||Senft, Christian: 1 article (07/2015)|
|10.||Zeiner, Pia S: 1 article (07/2015)|
12/16/1986 - "High doses of GAMS are required to provide protection against electroshock test (10 nmol) and limbic (40 nmol) seizures. "
12/16/1986 - "Protection against limbic and electroshock seizures is more pronounced after infusion of GAMS into substantia nigra than into the entopeduncular nucleus. "
09/25/1992 - "In addition, AP7 (0.05, 0.1 and 1.0 nmol) or GAMS (40 nmol) injected into the pedunculopontine nucleus suppressed limbic seizures induced by i.p. "
06/01/1991 - "When the kindled AM was stimulated at the previously established generalized seizure triggering threshold (GST) one hour after the GAMS (1 or 2 mumol) injection, afterdischarge (AD) generation was completely suppressed. "
02/13/1989 - "AP7, 0.025 mumol, blocked myoclonic seizures induced by L-HCA and D,L-HCA, and had no anticonvulsant action against D-HCA, gamma-D-GAMS, 0.5 mumol, was preferentially active against myoclonic seizures induced by D-HCA, had moderate anticonvulsant action against D,L-HCA, and no effect against seizures induced by L-HCA. "
12/01/2014 - "Importantly, GAMs and MDSCs have been reported to impair the efficacy of glioma therapy, in particular immunotherapeutic approaches. "
07/01/2015 - "In summary, CD74 expression in human gliomas is restricted to GAMs and positively associated with patient survival. "
12/01/2014 - "Therefore, advancing our understanding of the function of GAMs and MDSCs in brain tumours and targeted intervention of their immunosuppressive function may benefit the treatment of glioma. "
12/01/2014 - "Finally, GAMs and MDSCs enhance immune suppression in the glioma microenvironment and promote glioma growth, invasiveness, and neovascularization. "
12/01/2014 - "Glioma cells recruit GAMs and MDSCs to the tumour site and block their maturation. "
05/01/1996 - "Both responses gradually decreased over the experimental period of 50 min. The allodynia induced by strychnine was dose-dependently relieved by NMDA receptor antagonists (D-AP5, ketamine, and 7-C1-KYNA) and non-NMDA receptor antagonists (GAMS and CNQX) but not by metabotropic receptor antagonists (L-AP3 and L-AP4). "
05/01/1994 - "Non-NMDA receptor antagonists GAMS and CNQX inhibited both PGE2- and PGF2 alpha-induced allodynia. "
04/01/1997 - "3. The NMDA receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid (D-AP5), the non-NMDA receptor antagonist 7-D-glutamylaminomethyl sulphonic acid (GAMS), and the nitric oxide synthase inhibitor N epsilon-nitro-L-arginine methyl ester (L-NAME) inhibited the PGE2-induced hyperalgesia in wild-type mice. "
05/01/1996 - "On the other hand, allodynia induced by bicuculline was dose-dependently relieved by GAMS, L-AP3, and L-AP4, but not by D-AP5, ketamine, 7-C1-KYNA, and CNQX. "
06/01/1997 - "4. The allodynia evoked by nociceptin and morphine were dose-dependently blocked by glycine, D(-)-2-amino-5-phosphonovaleric acid (D-AP5, an N-methyl-D-aspartate (NMDA) receptor antagonist), gamma-D-glutamylaminomethyl sulphonic acid (GAMS, a non-NMDA receptor antagonist) and methylene blue (a soluble guanylate cyclase inhibitor), but were not affected by muscimol (a gamma-aminobutyric acidA (GABAA) receptor agonist) and baclofen (a GABAB receptor agonist). "
|4.||Spinal Cord Injuries (Spinal Cord Injury)
04/01/2015 - "GAMs only partially contributed to the overall TSPO expression within the tumors, and TSPO expression in GAMs did not correlate with tumor BPND. "
04/01/2015 - "The tumor tissue was quantitatively assessed for TSPO expression and infiltration of GAMs using immunohistochemistry and double immunofluorescence. "
01/01/2015 - "Generalized additive models (GAMs) with bivariate smoothing functions have been applied to estimate spatial variation in risk for many types of cancers. "
09/15/2014 - "Here, we demonstrate that STI1 expression in both the tumor and in the infiltrating GAMs and lymphocytes significantly increased with tumor progression. "
10/01/2005 - "It is proposed that generalized additive models (GAMs) are practical for cancer rate prediction. "
|2.||6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)
|8.||Kainic Acid (Kainate)
|10.||Kynurenic Acid (Kynurenate)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)